← back to search

Marwan Abouljoud

Virginia Commonwealth University · US
Area of research
Surgery · Hepatology
Research interest
Research focused on Liver transplantation and Transplantation, with related work in Ganciclovir, Demise, Hazard ratio. Notable publications include 'Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant', 'Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind,...', and 'The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study'.
h-index
citations
687
works
9
NIH funding
primary concept
email

Recent publications

From embedded interprofessional clinics to expanded alcohol-associated liver disease programs
Liver Transplantation 2025cited by 2position: middledoi
Liver Transplant Costs and Activity After United Network for Organ Sharing Allocation Policy Changes
JAMA Surgery 2024cited by 20position: middledoi
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference
Clinical Transplantation 2023cited by 12position: middledoi
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant
JAMA Surgery 2022cited by 393position: middledoi
What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium
HPB 2022cited by 0position: middledoi
Impact of the acuity circle model for liver allocation on multivisceral transplant candidates
American Journal of Transplantation 2021cited by 22position: middledoi
The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study
American Journal of Transplantation 2020cited by 51position: middledoi
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
American Journal of Transplantation 2020cited by 50position: middledoi
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
American Journal of Transplantation 2012cited by 137position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chandrashekhar A. Kubal · University of Birmingham2 papers (2021–2022)Kimberly Brown · University of Rochester Medical Center1 papers (2025–2025)Filza Hussain · Palo Alto University1 papers (2025–2025)Michael Nguyen · Palo Alto University1 papers (2022–2022)Shivali Patel · Henry Ford Health System1 papers (2025–2025)Swaytha Ganesh · University of Pittsburgh Medical Center1 papers (2023–2023)D. J. Winston · Los Angeles Medical Center1 papers (2012–2012)Miguel Navasa · Universitat de Barcelona1 papers (2012–2012) · 1 papers (2023–2023)B.-G. Ericzon · Karolinska Institutet1 papers (2012–2012)L. Clough · University of Kansas1 papers (2012–2012)C. Medin · Emory University1 papers (2022–2022)Abhi Humar · University of Pittsburgh Medical Center1 papers (2022–2022) · 1 papers (2022–2022)Jean C. Emond · Columbia University Irving Medical Center1 papers (2023–2023) · 1 papers (2022–2022)Vatche G. Agopian · California NanoSystems Institute1 papers (2022–2022)Shunji Nagai · Indiana University School of Medicine1 papers (2021–2021)Sukru Emre · Yale Cancer Center1 papers (2023–2023)Mark Sturdevant · Seattle Children's Hospital1 papers (2023–2023)